USPTO serial 79414866
CENTILLION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 16, 2025
- Examiner
- DEMARCO,JOE P
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CENTILLION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter Kunin
Peter Kunin Downs Rachlin Martin PLLC199 Main Street, PO Box 190Burlington, VT 05402-0190United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; catalysts for chemical and biochemical processes; biochemical catalysts; synthetic catalysts for chemical and biochemical processes; catalyst supports, namely, catalyst carriers; supports for catalysts; nucleic acids other than for medical or veterinary purposes, namely, nucleic recombinant acids; nucleic acids for scientific purposes; nucleic acids other than for medical or veterinary purposes, namely, nucleic acid for use in nucleic acid amplification processes; nucleic acid sequencing programs other than for medical or veterinary purposes; chromatography chemicals, namely, chromatographic material for the treatment of nucleic acids for scientific laboratory use; nucleic acid reagents other than for medical or veterinary purposes, namely, nucleic acid reagents for use in forensic analysis; chemicals for use in multiplying nucleic acid amounts other than for medical and veterinary use; chemicals for use in performing nucleic acid polymerase chain reactions other than for medical and veterinary use; stem cells for research or scientific purposes; chemical additives for use in fermentation; enzymes for use in the field of scientific and medical research, namely, enzymes for use in fermentation; proteins in raw material form for use in the field of scientific and medical research, namely, proteins for use in fermentation; ribonucleic acids other than for medical or veterinary purposes, namely, synthetic ribonucleic acid; synthetic messenger ribonucleic acid, other than for medical use; cell cultures, other than for medical use, namely, cell cultures for scientific purposes; proteins in raw material form for use in the field of scientific and medical research, namely, proteins for use in cell expansion and synthesis, other than for medical use; reagents for use in scientific research; monoclonal antibodies for scientific or research use; ferments for chemical purposes, namely, milk ferments for industrial chemical purposes; enzymes for scientific purposes | ACTIVE | — |
| 005 | Pharmaceutical preparations, namely, RNA-based vaccines, RNA-based therapies for the treatment of cancers and auto-immune diseases, and protein replacement therapies for the treatment of cancers and auto-immune diseases; medical preparations, namely, diagnostic preparations for medical purposes; nucleic acid sequences for medical and veterinary purposes; nucleic acid for use in nucleic acid amplification processes for medical use; nucleic acid sequencing programs for medical use; chemical reagents for medical use, namely, chemicals for use in multiplying nucleic acid amounts for medical use; chemical reagents for medical use, namely, chemicals for use in performing nucleic acid polymerase chain reactions for medical use; pharmaceutical preparations being RNA-based therapies and vaccines, namely, pharmaceutical preparations containing stem cells for the treatment of cancers and autoimmune diseases; stem cells for medical purposes; surgical implants comprised of living tissues, namely, surgical implants grown from stem cells; synthetic ribonucleic acid for medical use; synthetic messenger ribonucleic acid for medical use; cell cultures for medical use; protein arrays for use in cell expansion and synthesis for medical use; vaccines; vaccines for human use; biologics for human use, namely, biological reagents for medical use; hormones for medical purposes; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, immunomodulators; immunostimulants; antibodies for medical purposes; reagents for medical purposes; antibiotics; therapeutic protein arrays for medical purposes for RNA-based therapies and vaccines; ferments for pharmaceutical purposes; enzymes for medical purposes | ACTIVE | — |
| 007 | Chemical processing machines for use in synthesis, modification, catalysis, analysis, transport or storage of chemicals, nucleic acids, chemical mixes, reagents or reactants; filtration machines, namely, machines used for process filtration in the pharmaceutical industry; machine parts, namely, washers for apparatus and instruments for regulating or controlling chemical reactions, biochemical processes or biological processes between chemicals within pharmaceutical and vaccine manufacturing systems; reactors being industrial chemical installations; industrial chemical reactors, namely, reactors for gas-gas reactions; industrial chemical reactors, namely, reactors for gas-solids reactions | ACTIVE | — |
| 009 | Scientific apparatus and instruments for measuring DNA, RNA and protein; weighing apparatus and instruments for laboratory use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; laboratory apparatus and instruments for measuring characteristics of RNA for laboratory use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; scientific research and laboratory apparatus and equipment, namely, laboratory chemical reactors, flow reactors for laboratory use, baffled flow reactors for laboratory use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; scientific apparatus and instruments for routing, regulating or controlling the flow of chemicals within pharmaceutical and vaccine manufacturing systems for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; scientific apparatus and instruments for regulating or controlling the reactions between chemicals within pharmaceutical and vaccine manufacturing systems for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; downloadable computer firmware for operating chemical reactors for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; downloadable computer software for operating chemical reactors for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; software downloadable from the Internet for operating chemical reactors for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; downloadable electronic publications in the nature of journals in the field of scientific and medical research; laboratory chemical reactors; scientific apparatus, namely, flow reactors and baffled flow reactors for laboratory use; modular chemical reactors for laboratory use; reconfigurable chemical reactors for laboratory use; bio photochemical reactors for laboratory use; photochemical reactors for laboratory use; nucleic acid sequencers for scientific purposes; laboratory apparatus for fermentation; scientific apparatus, namely, filtration membranes for laboratory apparatus for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; feedback control systems comprised primarily of microprocessors, sensors, programmable logic controllers, graphics processing units, and microcontrollers for laboratory chemical reactors downloadable computer software for operating chemical reactors; downloadable software for the design of theoretical chemical structures for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; downloadable genetic algorithm software, namely, downloadable computer software used to solve optimisation problems based on natural selection; reaction chambers for laboratory use; scientific apparatus, namely, baffles for routing, regulating or controlling the flow of chemicals or reagents within pharmaceutical and vaccine manufacturing systems for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; blades being parts of laboratory apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within pharmaceutical and vaccine manufacturing systems for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; membranes for laboratory apparatus, namely, membranes for use as part of chemical reactors for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; parts for laboratory chemical reactors, namely, supports specifically adapted for apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within pharmaceutical and vaccine manufacturing systems; scientific mixing systems comprised primarily of a flow bioreactor, a fluid oscillator, fluidic pumps, fluidic valves, heat transfer systems, static fluid mixing systems, and microfluidic reactor chips used in connection with apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within a flow bioreactor system for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; injection systems comprised primarily of fluid dispensing pumps, syringe pumps, peristaltic pumps, piston pumps, selector valves, and non-return valves used in connection with apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within pharmaceutical and vaccine manufacturing systems; custom components for apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within a system, namely, custom laboratory chemical reactors for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; coated components for apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within a system, namely, coated laboratory chemical reactors; printed components for apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within a system, namely, printed laboratory chemical reactors; none of the aforesaid being apparatus, instruments, computer hardware or computer software for use in engineering design | ACTIVE | — |
| 011 | valves for controlling fluid levels in pharmaceutical and vaccine manufacturing systems; bioreactors for use in the treatment of waste, namely, biological reactors for clarifying industrial effluents; sterilisation equipment for use in laboratories, namely, chemical sterilization units; fluid separation apparatus, namely, extraction columns for use in the scientific research, medical research and pharmaceutical industries; apparatus and instruments for heating and cooling chemicals within pharmaceutical and vaccine manufacturing systems | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis and testing in the fields of flow chemistry, scientific research, medical research and pharmaceutical manufacture; industrial analysis services, namely, chemical analysis for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; industrial research services in the field of chemistry for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; design and development of computer hardware and software for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; computer programming for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; installation, maintenance and repair of computer software for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; chemical design services, namely, custom design and development of chemical reagents and biochemical assays for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; design for others in the field of chemistry, namely, services for the design of theoretical chemical structures for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; design for others in the field of chemistry, namely, services for the design of substances which possess specific properties for use in the fields of gene therapy research, vaccine research and development, research and development of medicines, research and development of pharmaceuticals, and research and development of medicines being biologics; biotechnology research; biotechnology research, namely, biotechnology testing; gene therapy research; vaccine research and development services; research and development of medicines; research and development of pharmaceuticals; research and development of medicines being biologics; scientific research and development, namely, research and development in relation to biomanufacturing; information, advice and consultancy in relation to the aforesaid services; none of the aforesaid services being engineering design services | ACTIVE | — |
| 044 | Stem cell therapy services; information, advice and consultancy in relation to the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Centillion Technology Limited
- Other trademarks owned by Centillion Technology Limited
- Other trademarks owned by Centillion Technology Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 011
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CENTILLION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 2, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 30, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 30, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 15, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 15, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 16, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 5, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 16, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 16, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 28, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 28, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 22, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 29, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 29, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 29, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 29, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 29, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 11, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 10, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 12, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 12, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 25, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 17, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 17, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 16, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |